{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:25:02Z","timestamp":1792034702902,"version":"4.4.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00403-018-1879-8","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:15:48Z","timestamp":1543302948000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["The role of PI3K\/AKT\/FOXO signaling in psoriasis"],"prefix":"10.1007","volume":"311","author":[{"given":"Miao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"1879_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/BST20110609","volume":"40","author":"E Aksamitiene","year":"2012","unstructured":"Aksamitiene E, Kiyatkin A, Kholodenko BN (2012) Cross-talk between mitogenic Ras\/MAPK and survival PI3K\/Akt pathways: a fine balance. Biochem Soc Trans 40:139\u2013146","journal-title":"Biochem Soc Trans"},{"key":"1879_CR2","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr2333","volume":"11","author":"B Aktas","year":"2009","unstructured":"Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R et al (2009) Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11:R46","journal-title":"Breast Cancer Res"},{"key":"1879_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ceb.2014.12.001","volume":"33","author":"V Albert","year":"2015","unstructured":"Albert V, Hall MN (2015) mTOR signaling in cellular and organismal energetics. Curr Opin Cell Biol 33:55\u201366","journal-title":"Curr Opin Cell Biol"},{"key":"1879_CR4","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-17-1171","volume":"77","author":"AG Amin","year":"2017","unstructured":"Amin AG, Wang A, Braun A, Tobias M, Murali R et al (2017) Abstract 3125: Therapeutic implications of mTORC1 and mTORC2 inhibitors in genetically heterogeneous glioblastoma. Can Res 77:3125\u20133125","journal-title":"Can Res"},{"key":"1879_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1721727X1401200213","volume":"12","author":"A Balato","year":"2014","unstructured":"Balato A, Caprio RD, Lembo S, Mattii M, Megna M et al (2014) Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm 12:341\u2013350","journal-title":"Eur J Inflamm"},{"key":"1879_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/exd.13267","volume":"26","author":"A Balato","year":"2017","unstructured":"Balato A, Lembo S, Ayala F, Balato N, Caiazzo G et al (2017) Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-alpha treatment. Exp Dermatol 26:325\u2013327","journal-title":"Exp Dermatol"},{"key":"1879_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1535-6108(04)00081-9","volume":"5","author":"S Bao","year":"2004","unstructured":"Bao S, Ouyang G, Bai X, Huang Z, Ma C et al (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt\/PKB pathway. Cancer Cell 5:329\u2013339","journal-title":"Cancer Cell"},{"key":"1879_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1042\/bst0310292","volume":"31","author":"KU Birkenkamp","year":"2003","unstructured":"Birkenkamp KU, Coffer PJ (2003) Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 31:292\u2013297","journal-title":"Biochem Soc Trans"},{"key":"1879_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/157436211795659883","volume":"6","author":"AW Bradley","year":"2011","unstructured":"Bradley AW, James ED, Charles JM (2011) New organ-specific pharmacological strategies interfering with signaling pathways in inflammatory disorders\/autoimmune disorders. Curr Signal Transduct Ther 6:279\u2013291","journal-title":"Curr Signal Transduct Ther"},{"key":"1879_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0968-0004(01)01958-2","volume":"26","author":"DP Brazil","year":"2001","unstructured":"Brazil DP, Hemmings BA (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26:657\u2013664","journal-title":"Trends Biochem Sci"},{"key":"1879_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857\u2013868","journal-title":"Cell"},{"key":"1879_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1083\/jcb.200112059","volume":"156","author":"A Brunet","year":"2002","unstructured":"Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D et al (2002) 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 156:817\u2013828","journal-title":"J Cell Biol"},{"key":"1879_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/bjd.12271","volume":"169","author":"C Buerger","year":"2013","unstructured":"Buerger C, Malisiewicz B, Eiser A, Hardt K, Boehncke WH (2013) Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin. Br J Dermatol 169:156\u2013159","journal-title":"Br J Dermatol"},{"key":"1879_CR14","doi-asserted-by":"publisher","first-page":"e0180853","DOI":"10.1371\/journal.pone.0180853","volume":"12","author":"C Buerger","year":"2017","unstructured":"Buerger C, Shirsath N, Lang V, Berard A, Diehl S et al (2017) Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation. PLoS One 12:e0180853","journal-title":"PLoS One"},{"key":"1879_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2340\/00015555-2724","volume":"97","author":"C Burger","year":"2017","unstructured":"Burger C, Shirsath N, Lang V, Diehl S, Kaufmann R et al (2017) Blocking mTOR Signalling with Rapamycin ameliorates Imiquimod-induced Psoriasis in Mice. Acta Derm Venereol 97:1087\u20131094","journal-title":"Acta Derm Venereol"},{"key":"1879_CR16","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/onc.2008.29","volume":"27","author":"BM Burgering","year":"2008","unstructured":"Burgering BM (2008) A brief introduction to FOXOlogy. Oncogene 27:2258\u20132262","journal-title":"Oncogene"},{"key":"1879_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0968-0004(02)02113-8","volume":"27","author":"BM Burgering","year":"2002","unstructured":"Burgering BM, Kops GJ (2002) Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27:352\u2013360","journal-title":"Trends Biochem Sci"},{"key":"1879_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1189\/jlb.1202629","volume":"73","author":"BM Burgering","year":"2003","unstructured":"Burgering BM, Medema RH (2003) Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB\/Akt is off duty. J Leukoc Biol 73:689\u2013701","journal-title":"J Leukoc Biol"},{"key":"1879_CR19","doi-asserted-by":"publisher","first-page":"32856","DOI":"10.1074\/jbc.M506119200","volume":"280","author":"E Calautti","year":"2005","unstructured":"Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF (2005) Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280:32856\u201332865","journal-title":"J Biol Chem"},{"key":"1879_CR20","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/onc.2008.21","volume":"27","author":"DR Calnan","year":"2008","unstructured":"Calnan DR, Brunet A (2008) The FoxO code. Oncogene 27:2276\u20132288","journal-title":"Oncogene"},{"key":"1879_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655\u20131657","journal-title":"Science"},{"key":"1879_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","volume":"71","author":"A Carracedo","year":"2011","unstructured":"Carracedo A, Alimonti A, Pandolfi PP (2011) PTEN level in tumor suppression: how much is too little? Cancer Res 71:629\u2013633","journal-title":"Cancer Res"},{"key":"1879_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2016.6769","volume":"26","author":"JC Chamcheu","year":"2017","unstructured":"Chamcheu JC, Adhami VM, Esnault S, Sechi M, Siddiqui IA et al (2017) Dual Inhibition of PI3K\/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice. Antioxid Redox Signal 26:49\u201369","journal-title":"Antioxid Redox Signal"},{"key":"1879_CR24","first-page":"854","volume":"96","author":"JC Chamcheu","year":"2016","unstructured":"Chamcheu JC, Chaves-Rodriquez MI, Adhami VM, Siddiqui IA, Wood GS et al (2016) Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPARbeta\/delta in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model. Acta Derm Venereol 96:854\u2013856","journal-title":"Acta Derm Venereol"},{"key":"1879_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000368445","volume":"28","author":"JC Chamcheu","year":"2015","unstructured":"Chamcheu JC, Pal HC, Siddiqui IA, Adhami VM, Ayehunie S et al (2015) Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis. Skin Pharmacol Physiol 28:177\u2013188","journal-title":"Skin Pharmacol Physiol"},{"key":"1879_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/jid.2012.333","volume":"133","author":"L Chen","year":"2013","unstructured":"Chen L, Wu J, Pier E, Zhao Y, Shen Z (2013) mTORC2-PKBalpha\/Akt1 Serine 473 phosphorylation axis is essential for regulation of FOXP3 stability by chemokine CCL3 in psoriasis. J Invest Dermatol 133:418\u2013428","journal-title":"J Invest Dermatol"},{"key":"1879_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2133.2008.08903.x","volume":"160","author":"SJ Chen","year":"2009","unstructured":"Chen SJ, Nakahara T, Takahara M, Kido M, Dugu L et al (2009) Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2. Br J Dermatol 160:442\u2013445","journal-title":"Br J Dermatol"},{"key":"1879_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","volume":"26","author":"E Christophers","year":"2001","unstructured":"Christophers E (2001) Psoriasis\u2013epidemiology and clinical spectrum. Clin Exp Dermatol 26:314\u2013320","journal-title":"Clin Exp Dermatol"},{"key":"1879_CR29","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.celrep.2016.11.006","volume":"17","author":"M Coffre","year":"2016","unstructured":"Coffre M, Benhamou D, Riess D, Blumenberg L, Snetkova V et al (2016) miRNAs are essential for the regulation of the PI3K\/AKT\/FOXO pathway and receptor editing during B cell maturation. Cell Rep 17:2271\u20132285","journal-title":"Cell Rep"},{"key":"1879_CR30","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/jid.2013.3","volume":"133","author":"A Datta Mitra","year":"2013","unstructured":"Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R et al (2013) 1alpha,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT\/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol 133:1556\u20131564","journal-title":"J Invest Dermatol"},{"key":"1879_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.22.012703.104721","volume":"22","author":"JA Deane","year":"2004","unstructured":"Deane JA, Fruman DA (2004) Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 22:563\u2013598","journal-title":"Annu Rev Immunol"},{"key":"1879_CR32","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499\u20133511","journal-title":"Genes Dev"},{"key":"1879_CR33","doi-asserted-by":"publisher","first-page":"13226","DOI":"10.1038\/ncomms13226","volume":"7","author":"X Ding","year":"2016","unstructured":"Ding X, Bloch W, Iden S, Ruegg MA, Hall MN et al (2016) mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. Nat Commun 7:13226","journal-title":"Nat Commun"},{"key":"1879_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0955-0674(98)80149-X","volume":"10","author":"J Downward","year":"1998","unstructured":"Downward J (1998) Mechanisms and consequences of activation of protein kinase B\/Akt. Curr Opin Cell Biol 10:262\u2013267","journal-title":"Curr Opin Cell Biol"},{"key":"1879_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BM (2013) FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 14:83\u201397","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1879_CR36","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606\u2013619","journal-title":"Nat Rev Genet"},{"key":"1879_CR37","first-page":"201","volume":"462","author":"A Essafi","year":"2009","unstructured":"Essafi A, Gomes AR, Pomeranz KM, Zwolinska AK, Varshochi R et al (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K\/Akt. Methods Mol Biol 462:201\u2013211","journal-title":"Methods Mol Biol"},{"key":"1879_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd2062","volume":"5","author":"S Faivre","year":"2006","unstructured":"Faivre S, Kroemer G, Raymond E (2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5:671\u2013688","journal-title":"Nat Rev Drug Discov"},{"key":"1879_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00403-018-1808-x","volume":"310","author":"AG Florek","year":"2018","unstructured":"Florek AG, Wang CJ, Armstrong AW (2018) Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res 310:271\u2013319","journal-title":"Arch Dermatol Res"},{"key":"1879_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2006.07602.x","volume":"156","author":"E Frigerio","year":"2007","unstructured":"Frigerio E, Colombo MD, Franchi C, Altomare A, Garutti C et al (2007) Severe psoriasis treated with a new macrolide: everolimus. Br J Dermatol 156:372\u2013374","journal-title":"Br J Dermatol"},{"key":"1879_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC et al (2017) The PI3K pathway in human disease. Cell 170:605\u2013635","journal-title":"Cell"},{"key":"1879_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","volume":"67","author":"DA Fruman","year":"1998","unstructured":"Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481\u2013507","journal-title":"Annu Rev Biochem"},{"key":"1879_CR43","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","volume":"8","author":"E Gonzalez","year":"2009","unstructured":"Gonzalez E, McGraw TE (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8:2502\u20132508","journal-title":"Cell Cycle"},{"key":"1879_CR44","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","volume":"24","author":"EL Greer","year":"2005","unstructured":"Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410\u20137425","journal-title":"Oncogene"},{"key":"1879_CR45","doi-asserted-by":"publisher","first-page":"17184","DOI":"10.1074\/jbc.274.24.17184","volume":"274","author":"S Guo","year":"1999","unstructured":"Guo S, Rena G, Cichy S, He X, Cohen P et al (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274:17184\u201317192","journal-title":"J Biol Chem"},{"key":"1879_CR46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/jcb.20200","volume":"93","author":"D Gupta","year":"2004","unstructured":"Gupta D, Syed NA, Roesler WJ, Khandelwal RL (2004) Effect of overexpression and nuclear translocation of constitutively active PKB-alpha on cellular survival and proliferation in HepG2 cells. J Cell Biochem 93:513\u2013525","journal-title":"J Cell Biochem"},{"issue":"8","key":"1879_CR47","first-page":"1","volume":"310","author":"M Gutknecht","year":"2018","unstructured":"Gutknecht M, Schaarschmidt ML, Danner M, Otten M, Augustin M (2018) How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scales. Arch Dermatol Res 310(8):1\u201311","journal-title":"Arch Dermatol Res"},{"key":"1879_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00403-017-1751-2","volume":"309","author":"R Hambly","year":"2017","unstructured":"Hambly R, Kirby B (2017) The relevance of serum vitamin D in psoriasis: a review. Arch Dermatol Res 309:499\u2013517","journal-title":"Arch Dermatol Res"},{"key":"1879_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10753-013-9715-y","volume":"37","author":"JQ Hao","year":"2014","unstructured":"Hao JQ (2014) Targeting interleukin-22 in psoriasis. Inflammation 37:94\u201399","journal-title":"Inflammation"},{"key":"1879_CR50","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4:988\u20131004","journal-title":"Nat Rev Drug Discov"},{"key":"1879_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/bjd.14106","volume":"174","author":"KK Hong","year":"2016","unstructured":"Hong KK, Gwak MJ, Song J, Kim NI (2016) Nuclear factor-kappaB pathway activation and phosphatase and tensin homolog downregulation in psoriasis. Br J Dermatol 174:433\u2013435","journal-title":"Br J Dermatol"},{"key":"1879_CR52","doi-asserted-by":"publisher","first-page":"21615","DOI":"10.1074\/jbc.M302937200","volume":"278","author":"RC Hresko","year":"2003","unstructured":"Hresko RC, Murata H, Mueckler M (2003) Phosphoinositide-dependent kinase-2 is a distinct protein kinase enriched in a novel cytoskeletal fraction associated with adipocyte plasma membranes. J Biol Chem 278:21615\u201321622","journal-title":"J Biol Chem"},{"key":"1879_CR53","first-page":"737","volume":"30","author":"L Huang","year":"2014","unstructured":"Huang L, Xue R (2014) The expressions of p-Akt and p-FoxO1 in the lesions of psoriasis vulgaris (in Chinese). Chin J Leprosy Skin Dis 30:737\u2013739","journal-title":"Chin J Leprosy Skin Dis"},{"key":"1879_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2340\/00015555-1737","volume":"94","author":"T Huang","year":"2014","unstructured":"Huang T, Lin X, Meng X, Lin M (2014) Phosphoinositide-3 kinase\/protein kinase-B\/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target? Acta Derm Venereol 94:371\u2013379","journal-title":"Acta Derm Venereol"},{"key":"1879_CR55","doi-asserted-by":"publisher","first-page":"92032","DOI":"10.18632\/oncotarget.20734","volume":"8","author":"M Imai-Sumida","year":"2017","unstructured":"Imai-Sumida M, Chiyomaru T, Majid S, Saini S, Nip H et al (2017) Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K\/Akt signaling pathways. Oncotarget 8:92032\u201392042","journal-title":"Oncotarget"},{"key":"1879_CR56","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.200505087","volume":"171","author":"HY Irie","year":"2005","unstructured":"Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P et al (2005) Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171:1023\u20131034","journal-title":"J Cell Biol"},{"key":"1879_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0065-230X(09)02002-8","volume":"102","author":"BH Jiang","year":"2009","unstructured":"Jiang BH, Liu LZ (2009) PI3K\/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102:19\u201365","journal-title":"Adv Cancer Res"},{"key":"1879_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.14.2.142","volume":"14","author":"KH Kaestner","year":"2000","unstructured":"Kaestner KH, Knochel W, Martinez DE (2000) Unified nomenclature for the winged helix\/forkhead transcription factors. Genes Dev 14:142\u2013146","journal-title":"Genes Dev"},{"key":"1879_CR59","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature08980","volume":"464","author":"CJ Kenyon","year":"2010","unstructured":"Kenyon CJ (2010) The genetics of ageing. Nature 464:504\u2013512","journal-title":"Nature"},{"key":"1879_CR60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1469-7580.2000.19740571.x","volume":"4","author":"GJ Kops","year":"2000","unstructured":"Kops GJ, Burgering BM (2000) Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT). J Anat 197 Pt 4:571\u2013574","journal-title":"J Anat 197 Pt"},{"key":"1879_CR61","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s001099900050","volume":"77","author":"GJ Kops","year":"1999","unstructured":"Kops GJ, Burgering BM (1999) Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med (Berl) 77:656\u2013665","journal-title":"J Mol Med (Berl)"},{"key":"1879_CR62","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/19328","volume":"398","author":"GJ Kops","year":"1999","unstructured":"Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL et al (1999) Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630\u2013634","journal-title":"Nature"},{"key":"1879_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"1879_CR64","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943\u20131947","journal-title":"Science"},{"key":"1879_CR65","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11427-016-9050-6","volume":"61","author":"Q Li","year":"2018","unstructured":"Li Q, Huang H, He Z, Sun Y, Tang Y et al (2018) Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. Sci China Life Sci 61:550\u2013558","journal-title":"Sci China Life Sci"},{"key":"1879_CR66","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/ijd.12061","volume":"53","author":"Y Li","year":"2014","unstructured":"Li Y, Man X, You L, Xiang Q, Li H et al (2014) Downregulation of PTEN expression in psoriatic lesions. Int J Dermatol 53:855\u2013860","journal-title":"Int J Dermatol"},{"key":"1879_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett MB et al (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187:490\u2013500","journal-title":"J Immunol"},{"key":"1879_CR68","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1007\/s11033-010-0544-x","volume":"38","author":"Y Liu","year":"2011","unstructured":"Liu Y, Luo W, Chen S (2011) Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A\/B and EZH2 in lesional psoriatic skins. Mol Biol Rep 38:4219\u20134224","journal-title":"Mol Biol Rep"},{"key":"1879_CR69","doi-asserted-by":"publisher","first-page":"R236","DOI":"10.1016\/S0960-9822(02)00777-7","volume":"12","author":"JM Lizcano","year":"2002","unstructured":"Lizcano JM, Alessi DR (2002) The insulin signalling pathway. Curr Biol 12:R236\u2013R238","journal-title":"Curr Biol"},{"key":"1879_CR70","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866\u2013873","journal-title":"Nature"},{"key":"1879_CR71","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","volume":"34","author":"MA Lowes","year":"2013","unstructured":"Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG (2013) The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 34:174\u2013181","journal-title":"Trends Immunol"},{"key":"1879_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2018.01.018","volume":"50","author":"J Ma","year":"2018","unstructured":"Ma J, Matkar S, He X, Hua X (2018) FOXO family in regulating cancer and metabolism. Semin Cancer Biol 50:32\u201341","journal-title":"Semin Cancer Biol"},{"key":"1879_CR73","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1038\/cddis.2012.69","volume":"3","author":"S Madonna","year":"2012","unstructured":"Madonna S, Scarponi C, Pallotta S, Cavani A, Albanesi C (2012) Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. Cell Death Dis 3:e334","journal-title":"Cell Death Dis"},{"key":"1879_CR74","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1248\/bpb.30.1624","volume":"30","author":"T Maehama","year":"2007","unstructured":"Maehama T (2007) PTEN: its deregulation and tumorigenesis. Biol Pharm Bull 30:1624\u20131627","journal-title":"Biol Pharm Bull"},{"key":"1879_CR75","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","volume":"273","author":"T Maehama","year":"1998","unstructured":"Maehama T, Dixon JE (1998) The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375\u201313378","journal-title":"J Biol Chem"},{"key":"1879_CR76","doi-asserted-by":"crossref","unstructured":"Malemud CJ (2009) The discovery of novel experimental therapies for inflammatory arthritis. Mediat Inflamm 2009: 698769","DOI":"10.1155\/2009\/698769"},{"key":"1879_CR77","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4155\/fmc.15.55","volume":"7","author":"CJ Malemud","year":"2015","unstructured":"Malemud CJ (2015) The PI3K\/Akt\/PTEN\/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? Fut Med Chem 7:1137\u20131147","journal-title":"Fut Med Chem"},{"key":"1879_CR78","first-page":"338","volume":"25","author":"X Man","year":"2011","unstructured":"Man X, Zhang X, Li H (2011) The Expression of Akt1,Akt2,Akt3 in the lesions of Psoriasis vulgaris the Chinese (in Chinese). J Dermatovenereol 25:338\u2013340","journal-title":"J Dermatovenereol"},{"key":"1879_CR79","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704\u2013715","journal-title":"Cell"},{"key":"1879_CR80","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB Signaling: navigating the network. Cell 169:381\u2013405","journal-title":"Cell"},{"key":"1879_CR81","doi-asserted-by":"publisher","first-page":"530","DOI":"10.18632\/oncotarget.188","volume":"1","author":"B Markman","year":"2010","unstructured":"Markman B, Dienstmann R, Tabernero J (2010) Targeting the PI3K\/Akt\/mTOR pathway\u2013beyond rapalogs. Oncotarget 1:530\u2013543","journal-title":"Oncotarget"},{"key":"1879_CR82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-1-62703-167-7_37","volume-title":"Bioactive dietary factors and plant extracts in dermatology nutrition and health","author":"BC Melnik","year":"2013","unstructured":"Melnik BC (2013) Western diet-mediated mTORC1-signaling in Acne, psoriasis, atopic dermatitis, and related diseases of civilization: therapeutic role of plant-derived natural mTORC1 inhibitors. In: Watson R, Zibadi S (eds) Bioactive dietary factors and plant extracts in dermatology nutrition and health. Humana Press, Totowa, pp\u00a0397\u2013419"},{"key":"1879_CR83","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar3781","volume":"14","author":"A Mitra","year":"2012","unstructured":"Mitra A, Raychaudhuri SK, Raychaudhuri SP (2012) Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 14:R65","journal-title":"Arthritis Res Ther"},{"key":"1879_CR84","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","volume":"60","author":"A Mitra","year":"2012","unstructured":"Mitra A, Raychaudhuri SK, Raychaudhuri SP (2012) IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade. Cytokine 60:38\u201342","journal-title":"Cytokine"},{"key":"1879_CR85","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.biopha.2017.08.025","volume":"94","author":"M Moeinifard","year":"2017","unstructured":"Moeinifard M, Hassan ZM, Fallahian F, Hamzeloo-Moghadam M, Taghikhani M (2017) Britannin induces apoptosis through AKT-FOXO1 pathway in human pancreatic cancer cells. Biomed Pharmacother 94:1101\u20131110","journal-title":"Biomed Pharmacother"},{"key":"1879_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/exd.12885","volume":"25","author":"G Monfrecola","year":"2016","unstructured":"Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R et al (2016) Mechanistic target of rapamycin (mTOR) expression is increased in acne patients\u2019 skin. Exp Dermatol 25:153\u2013155","journal-title":"Exp Dermatol"},{"key":"1879_CR87","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1038\/sj.onc.1210274","volume":"26","author":"K Murayama","year":"2007","unstructured":"Murayama K, Kimura T, Tarutani M, Tomooka M, Hayashi R et al (2007) Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors. Oncogene 26:4882\u20134888","journal-title":"Oncogene"},{"key":"1879_CR88","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G et al (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci USA 98:10314\u201310319","journal-title":"Proc Natl Acad Sci USA"},{"key":"1879_CR89","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496\u2013509","journal-title":"N Engl J Med"},{"key":"1879_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.sder.2010.03.001","volume":"29","author":"KE Nograles","year":"2010","unstructured":"Nograles KE, Davidovici B, Krueger JG (2010) New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 29:3\u20139","journal-title":"Semin Cutan Med Surg"},{"key":"1879_CR91","doi-asserted-by":"publisher","first-page":"17297","DOI":"10.1074\/jbc.M610386200","volume":"282","author":"RF O\u2019Shaughnessy","year":"2007","unstructured":"O\u2019Shaughnessy RF, Welti JC, Cooke JC, Avilion AA, Monks B et al (2007) AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. J Biol Chem 282:17297\u201317305","journal-title":"J Biol Chem"},{"key":"1879_CR92","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","volume":"258","author":"A Ochaion","year":"2009","unstructured":"Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R et al (2009) The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn\u2019s disease. Cell Immunol 258:115\u2013122","journal-title":"Cell Immunol"},{"key":"1879_CR93","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/40194","volume":"389","author":"S Ogg","year":"1997","unstructured":"Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L et al (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994\u2013999","journal-title":"Nature"},{"key":"1879_CR94","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1242\/jcs.03175","volume":"119","author":"S Pankow","year":"2006","unstructured":"Pankow S, Bamberger C, Klippel A, Werner S (2006) Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase. J Cell Sci 119:4033\u20134046","journal-title":"J Cell Sci"},{"key":"1879_CR95","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1101\/gad.12.16.2488","volume":"12","author":"S Paradis","year":"1998","unstructured":"Paradis S, Ruvkun G (1998) Caenorhabditis elegans Akt\/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12:2488\u20132498","journal-title":"Genes Dev"},{"key":"1879_CR96","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1101\/gad.1089403","volume":"17","author":"XD Peng","year":"2003","unstructured":"Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J et al (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352\u20131365","journal-title":"Genes Dev"},{"key":"1879_CR97","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/1523-1747.ep12696808","volume":"92","author":"MC Pike","year":"1989","unstructured":"Pike MC, Lee CS, Elder JT, Voorhees JJ, Fisher GJ (1989) Increased phosphatidylinositol kinase activity in psoriatic epidermis. J Invest Dermatol 92:791\u2013797","journal-title":"J Invest Dermatol"},{"key":"1879_CR98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/0019-5154.123499","volume":"59","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Raychaudhuri SP (2014) mTOR signaling cascade in psoriatic disease: double kinase mTOR inhibitor a novel therapeutic target. Indian J Dermatol 59:67\u201370","journal-title":"Indian J Dermatol"},{"key":"1879_CR99","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1002\/art.30564","volume":"63","author":"SP Raychaudhuri","year":"2011","unstructured":"Raychaudhuri SP, Raychaudhuri SK, Atkuri KR, Herzenberg LA, Herzenberg LA (2011) Nerve growth factor: a key local regulator in the pathogenesis of inflammatory arthritis. Arthritis Rheum 63:3243\u20133252","journal-title":"Arthritis Rheum"},{"key":"1879_CR100","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","volume":"178","author":"SM Sa","year":"2007","unstructured":"Sa SM, Valdez PA, Wu J, Jung K, Zhong F et al (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178:2229\u20132240","journal-title":"J Immunol"},{"key":"1879_CR101","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/stem.1565","volume":"32","author":"S Saoncella","year":"2014","unstructured":"Saoncella S, Tassone B, Deklic E, Avolio F, Jon C et al (2014) Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. Stem Cells 32:754\u2013769","journal-title":"Stem Cells"},{"key":"1879_CR102","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307:1098\u20131101","journal-title":"Science"},{"key":"1879_CR103","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/art.30278","volume":"63","author":"A Saxena","year":"2011","unstructured":"Saxena A, Raychaudhuri SK, Raychaudhuri SP (2011) Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent. Arthritis Rheum 63:1465\u20131466","journal-title":"Arthritis Rheum"},{"key":"1879_CR104","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 169:361\u2013371","journal-title":"Cell"},{"key":"1879_CR105","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1073\/pnas.95.13.7772","volume":"95","author":"PH Scott","year":"1998","unstructured":"Scott PH, Brunn GJ, Kohn AD, Roth RA, Lawrence JC Jr (1998) Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci USA 95:7772\u20137777","journal-title":"Proc Natl Acad Sci USA"},{"key":"1879_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-2187-3-7","volume":"3","author":"S Shankar","year":"2008","unstructured":"Shankar S, Chen Q, Srivastava RK (2008) Inhibition of PI3K\/AKT and MEK\/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal 3:1\u201311","journal-title":"J Mol Signal"},{"key":"1879_CR107","doi-asserted-by":"publisher","first-page":"52200","DOI":"10.1074\/jbc.M409630200","volume":"279","author":"Q Shi","year":"2004","unstructured":"Shi Q, Bao S, Maxwell JA, Reese ED, Friedman HS et al (2004) Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J Biol Chem 279:52200\u201352209","journal-title":"J Biol Chem"},{"key":"1879_CR108","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/exd.12779","volume":"24","author":"N Shirsath","year":"2015","unstructured":"Shirsath N, Mayer G, Singh TP, Wolf P (2015) 8-methoxypsoralen plus UVA (PUVA) therapy normalizes signalling of phosphorylated component of mTOR pathway in psoriatic skin of K5.hTGFbeta1 transgenic mice. Exp Dermatol 24:889\u2013891","journal-title":"Exp Dermatol"},{"key":"1879_CR109","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/1535-7163.MCT-14-0669","volume":"14","author":"HP Soares","year":"2015","unstructured":"Soares HP, Ming M, Mellon M, Young SH, Han L et al (2015) Dual PI3K\/mTOR inhibitors induce rapid overactivation of the MEK\/ERK Pathway in human pancreatic cancer cells through suppression of mTORC2. Mol Cancer Ther 14:1014\u20131023","journal-title":"Mol Cancer Ther"},{"key":"1879_CR110","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"G Song","year":"2005","unstructured":"Song G, Ouyang G, Bao S (2005) The activation of Akt\/PKB signaling pathway and cell survival. J Cell Mol Med 9:59\u201371","journal-title":"J Cell Mol Med"},{"key":"1879_CR111","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356\u2013362","journal-title":"Nat Genet"},{"key":"1879_CR112","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1126\/science.277.5325.567","volume":"277","author":"D Stokoe","year":"1997","unstructured":"Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB et al (1997) Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567\u2013570","journal-title":"Science"},{"key":"1879_CR113","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","volume":"1813","author":"G Tzivion","year":"2011","unstructured":"Tzivion G, Dobson M, Ramakrishnan G (2011) FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813:1938\u20131945","journal-title":"Biochim Biophys Acta"},{"key":"1879_CR114","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/onc.2008.22","volume":"27","author":"KE Vos van der","year":"2008","unstructured":"van der Vos KE, Coffer PJ (2008) FOXO-binding partners: it takes two to tango. Oncogene 27:2289\u20132299","journal-title":"Oncogene"},{"key":"1879_CR115","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ncb2536","volume":"14","author":"KE Vos van der","year":"2012","unstructured":"van der Vos KE, Eliasson P, Proikas-Cezanne T, Vervoort SJ, van Boxtel R et al (2012) Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat Cell Biol 14:829\u2013837","journal-title":"Nat Cell Biol"},{"key":"1879_CR116","first-page":"1512","volume":"37","author":"H Wang","year":"2017","unstructured":"Wang H, Ran LW, Hui K, Wang XY, Zheng Y (2017) Expressions of survivin, PI3K and AKT in keratinocytes in skin lesions and their pathogenic role in psoriasis vulgaris. Nan Fang Yi Ke Da Xue Xue Bao 37:1512\u20131516","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1879_CR117","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3892\/mmr.2016.5867","volume":"14","author":"Z Wang","year":"2016","unstructured":"Wang Z, Yu T, Huang P (2016) Post-translational modifications of FOXO family proteins (review). Mol Med Rep 14:4931\u20134941","journal-title":"Mol Med Rep"},{"key":"1879_CR118","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"HG Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S et al (2004) Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428:332\u2013337","journal-title":"Nature"},{"key":"1879_CR119","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1126\/science.7701324","volume":"267","author":"R Yao","year":"1995","unstructured":"Yao R, Cooper GM (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003\u20132006","journal-title":"Science"},{"key":"1879_CR120","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cub.2010.12.047","volume":"21","author":"TL Yuan","year":"2011","unstructured":"Yuan TL, Wulf G, Burga L, Cantley LC (2011) Cell-to-cell variability in PI3K protein level regulates PI3K-AKT pathway activity in cell populations. Curr Biol 21:173\u2013183","journal-title":"Curr Biol"},{"key":"1879_CR121","first-page":"1097","volume":"112","author":"X Zhang","year":"1999","unstructured":"Zhang X, Liu H, Ma S (1999) Up-regulation of phosphatidylinositol 3-kinase in psoriatic lesions. Chin Med J (Engl) 112:1097\u20131100","journal-title":"Chin Med J (Engl)"},{"key":"1879_CR122","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813:1978\u20131986","journal-title":"Biochim Biophys Acta"},{"key":"1879_CR123","first-page":"413","volume":"42","author":"X Zhang","year":"2009","unstructured":"Zhang X, Zhou P, You L (2009) Increased activities of Akt in psoriatic epidermis (in Chinese). Chin J Dermatol 42:413\u2013416","journal-title":"Chin J Dermatol"},{"key":"1879_CR124","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21\u201335","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1879-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T23:02:56Z","timestamp":1662505376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1879"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1879-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"19 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors; therefore, informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}